Product logins

Find logins to all Clarivate products below.


Anne Lecocq

Senior Vice President and General Manager, Research & Development

Anne Lecocq is a seasoned life sciences executive with over 20 years of experience. She began her career in the pharmaceutical and generics industries, specializing in regulatory compliance and chemistry, manufacturing and controls (CMC), before joining Clarivate in 2008.

At Clarivate, Anne has held multiple leadership roles overseeing data and content strategy for Cortellis solutions spanning drug discovery, clinical trials, competitive intelligence, safety, and regulatory intelligence. In her current role as General Manager of the R&D Business, she drives product innovation and strategic growth for the Cortellis product suite, enabling biopharma organizations to accelerate the delivery of life-changing therapies to patients through actionable intelligence and advanced analytics.

Anne holds dual master’s degrees in Biotechnology & Chemistry and Regulatory Affairs. Based in Paris, France, she is passionate about leveraging her multidisciplinary expertise to advance global R&D efficiency through transformative intelligence.

Related resources

Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
Biopharma Commercialization HMO HTA Launch Managed care MCO Payer PBM Pharma pricing
Understanding the impact of drug shortages across markets for API manufacturers Understanding the impact of drug shortages across markets for API manufacturers
Blog October 9, 2026
Understanding the impact of drug shortages across markets for API manufacturers
Biopharma Manufacturing Real-World Data Supply chain
From promise to payment: pricing and reimbursement for combination oncology regimens From promise to payment: pricing and reimbursement for combination oncology regimens
Blog October 9, 2026
From promise to payment: pricing and reimbursement for combination oncology regimens
Biopharma Biotech Bispecific antibodies BsAb Clinical trials Commercialization EMA EMEA Europe HTA Launch Market Access Oncology Payer Pharma Policy pricing
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research